Exploring the efficacy and safety of laparoscopic liver resection in the treatment of early-stage male patients with liver cancer and tumor diameter ≤5 cm

Background: This study investigates the efficacy and safety of laparoscopic hepatectomy in male patients with hepatocellular carcinoma (HCC) and tumor diameter ≤5 cm. Methods: The clinical data of 100 male HCC patients treated at our hospital from January 2019 to January 2021 were retrospectively collected. According to the treatment methods, patients were divided into an observation group (50 cases) and a control group (50 cases). The control group underwent traditional open non-anatomical liver resection, while the observation group received laparoscopic non-anatomical liver resection. The safety and efficacy of the two surgical methods were compared. Results: The observation group demonstrated significantly reduced intraoperative blood loss, operation time, incision length, and hepatic portal occlusion time than the control group (p < 0.001). The observation group had shorter times to mobilization, initiation of oral feeding, and hospital discharge (p < 0.001). On postoperative day three, levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL) were significantly lower in the observation group (p < 0.05). Cluster of Differentiation 3+ (CD3+), CD4+, CD8+, and CD4+/CD8+ ratio were improved in the observation group one week post-surgery (p < 0.05). The complication rate was significantly lower in the observation group (p < 0.05). At 1 and 3 years post-surgery, the recurrence rate in the observation group was significantly lower (p < 0.05). The overall survival (OS) rates at one, two, and three years were 75.9%, 41.4% and 12.9% for the observation group and 55.5%, 14.4% and 0% for the control group (p < 0.05), respectively. The median survival times in the observation group was significantly longer than the control group (p < 0.05). Conclusions: Laparoscopic hepatectomy for HCC offers improved clinical outcomes, enhanced liver function, reduced complication rates, and favorable safety profiles compared to open hepatectomy.

Laparoscopic hepatectomy; Hepatocellular carcinoma; Open hepatectomy

[1] Danpanichkul P, Suparan K, Sukphutanan B, Kaeosri C, Tothanarungroj P, Sirimangklanurak S, et al. Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region. Scientific Reports. 2024; 14: 19544.

[2] Almohammadi NH. Liver cancer in Saudi Arabia: a registry-based nationwide descriptive epidemiological and survival analysis. Cancer Epidemiology. 2025; 94: 102731.

[3] Motta BM, Masarone M, Torre P, Persico M. From non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): epidemiology, incidence, predictions, risk factors, and prevention. Cancers. 2023; 15: 5458.

[4] Singh SP, Madke T, Chand P. Global epidemiology of hepatocellular carcinoma. Journal of Clinical and Experimental Hepatology. 2025; 15: 102446.

[5] Polyzos SA, Chrysavgis L, Vachliotis ID, Chartampilas E, Cholongitas E. Nonalcoholic fatty liver disease and hepatocellular carcinoma: insights in epidemiology, pathogenesis, imaging, prevention and therapy. Seminars in Cancer Biology. 2023; 93: 20–35.

[6] Shoma B. Primary liver cancers: connecting the dots of cellular studies and epidemiology with metabolomics. International Journal of Molecular Sciences. 2023; 24: 2409.

[7] Wang X, Lin ZY, Zhou Y, Zhong Q, Li ZR, Lin XX, et al. Association of preoperative antiviral treatment with incidences of post-hepatectomy liver failure in hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastrointestinal Surgery. 2024; 16: 2106–2118.

[8] Watanabe Y, Aikawa M, Oshima Y, Kato T, Takase K, Watanabe Y, et al. Outcomes after laparoscopic or open liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: a propensity score-matching study. Surgical Endoscopy. 2024; 38: 3887–3904.

[9] Son SY, Geevarghese R, Marinelli B, Zhao K, Covey A, Maxwell A, et al. Conversion therapy to transplant or surgical resection in patients with unresectable hepatocellular carcinoma treated with boosted dose of yttrium-90 radiation segmentectomy. Cancers. 2024; 16: 3024.

[10] Cassese G, Han HS, Lee E, Lee B, Lee HW, Cho JY, et al. Laparoscopic versus open liver resection for multiple hepatocellular carcinoma within and beyond the Milan criteria: an Eastern-Western propensity score-matched analysis. Journal of Hepato-Biliary-Pancreatic Sciences. 2023; 31: 2–11.

[11] Han J, Kuai W, Yang L, Tao X, Wang Y, Zeng M, et al. Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma. Cancer Biology & Medicine. 2024; 21: 813–825.

[12] Shen S, Pan L. Effect of metabolic dysfunction‑associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: a systematic review and meta‑analysis. Experimental and Therapeutic Medicine. 2024; 27: 99.

[13] Campos WC, Villalobos CC, Márquez RM, Garavito-Rentería J, Huailla RZ. P-29 incidence and associated factors of hepatocellular carcinoma in patients with chronic hepatitis b infection in a single center in Peru: a retrospective study. Annals of Hepatology. 2024; 29: 101216.

[14] Bahri S, Brown L, Perin G, Balasubramanian SP. Comment on: Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial. The British Journal of Surgery. 2024; 111: znae171.

[15] Cillo U, Caregari S, Barabino M, Billato I, Marchini A, Furlanetto A, et al. Hierarchically positioning laparoscopic microwave ablation in the therapeutic span of early hepatocellular carcinoma: a real-life comparative analysis. Annals of Surgical Oncology. 2025; 32: 1063-1072.

[16] Kim JH. Laparoscopic subsegmentectomy 5 for deeply located hepatocellular carcinoma surrounded by major portal pedicles and middle hepatic vein. Surgical Oncology. 2024; 57: 102166.

[17] Yang S, Ni H, Zhang A, Zhang J, Liang H, Li X, et al. Grading severity of MVI impacts long-term outcomes after laparoscopic liver resection for early-stage hepatocellular carcinoma: a multicenter study. The American Journal of Surgery. 2024; 238: 115988.

[18] Wang X, Chai X, Tang R, Xu Y, Chen Q. Comparison of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma patients: a SEER population-based propensity score matching study. Updates in Surgery. 2024; 76: 2755–2766.

[19] Kitahama T, Ashida R, Ohgi K, Yamada M, Otsuka S, Kato Y, et al. Laparoscopic right anterior inferior segmentectomy for hepatocellular carcinoma in a patient with congenital absence of the portal vein: intrahepatic artery-guided simulation. The British Journal of Surgery. 2024; 111: znae210.

[20] Xiong D, Li J, Yuan S. Is laparoscopic hepatectomy superior to radiofrequency ablation in treating small hepatocellular carcinoma? Hepatology International. 2024; 18: 1815–1816.

[21] Wei Y, Zhang L, Zhang S, Song M, Ji C. Laparoscopic-assisted microwave ablation in treatment of small hepatocellular carcinoma: safety and efficacy in comparison with laparoscopic hepatectomy. BMC Surgery. 2024; 24: 138.

[22] Lee B, Cho JY, Han HS, Yoon YS, Lee HW, Kang M, et al. Association between unplanned conversion and patient survival after laparoscopic liver resection for hepatocellular carcinoma: a propensity score matched analysis. Journal of Clinical Medicine. 2024; 13: 1116.

[23] Ng KKC, Cheng KC, Kung JWC, Ho KM, Lok HT, Fung AKY, et al. Comparison of clinical outcome between laparoscopic and open hepatectomy of high difficulty score for hepatocellular carcinoma: a propensity score analysis. Surgical Endoscopy. 2024; 38: 857–871.

[24] Lee YH, Huang YT, Kuo TL, Lee MC, Chen YC. Laparoscopic hepatectomy is a feasible and safe choice for primary hepatocellular carcinoma located at favorable location during the development period of a tertiary hospital: a case-control study. Tzu Chi Medical Journal. 2024; 36: 418–424.

[25] Sakai H, Goto Y, Fukutomi S, Arai S, Midorikawa R, Hashimoto K, et al. Safety and feasibility of laparoscopic anatomical liver resection for hepatocellular carcinoma: a propensity score-matched study. Anticancer Research. 2024; 44: 3645–3653.

[26] Chinnappan R, Mir TA, Alsalameh S, Makhzoum T, Alzhrani A, Kattan KA, et al. Low-cost point-of-care monitoring of ALT and AST is promising for faster decision making and diagnosis of acute liver injury. Diagnostics. 2023; 13: 2967.

[27] Steggerda JA, Wisel SA, Nissen NN, Voidonikolas G, Kosari K. The role of laparoscopic surgery in the management of hepatocellular carcinoma. Current Hepatology Reports. 2024; 23: 378–388.

[28] Hoogteijling T, Sijberden J, Aldrighetti L, Cillo U, Vivarelli M, Besselink M, et al. Laparoscopic vs. open hepatectomy for giant hepatocellular carcinoma: a propensity score matched retrospective analysis of short- and long-term outcomes. European Journal of Surgical Oncology. 2024; 50: 107763.

[29] Kim KS, Choi GS, Rhu J, Kim J. Comparison between laparoscopic liver resection and open liver resection in patients with hepatocellular carcinoma with portal vein tumor thrombosis. Surgical Endoscopy. 2024; 38: 2116–2123.

[30] Xing F, Zhang L, Tang Z, Li X, Gong H, Wang B, et al. Effect of thoraco-laparoscopic esophagectomy on postoperative immune function of patients with esophageal carcinoma. Journal of Southern Medical University. 2021; 41: 146–150. (In Chinese)

[31] Tao Z, Qian L, Zhi L, Hua Y. Effect of laparoscopic complete mesocolic excision combined with immunotherapy and its impact on immune function and tumor markers in elderly patients with colon cancer. Pakistan Journal of Medical Sciences. 2023; 39: 1473–1477.

[32] Kitti W, Mati R, Jantaluck N, Papot C, Vorapatu T. Laparoscopic versus open liver resection for treatment of liver tumors: early experience outcomes. Formosan Journal of Surgery. 2024; 57: 11–16.

[33] Yosuke N, Tsuyoshi K, Masakazu H, Takashi O, Hiroaki M, Koichi O, et al. The efficacy and safety of pure laparoscopic liver resection for hepatocellular carcinoma in super-elderly patients over 80 years: a multicenter propensity analysis. Journal of Hepato-Biliary-Pancreatic Sciences. 2023; 31: 234–242.

[34] Wang AZ, Zhou R, Chen J, Zhang F, Du JY, Chen YJ, et al. Safety and efficacy of laparoscopic portal territory fluorescence navigation-guided anatomical liver resection in hepatocellular carcinoma patients. Surgical Endoscopy. 2025; 39: 2597–2608.